Production and characterization of a C15-surfactin-O-methyl ester by a lipopeptide producing strain Bacillus subtilis HSO121

Process Biochemistry

Volumn 44, Issue 10, 2009, Pages 1144-1151

  Liu, Xiang Yang ^a   Yang, Shi Zhong ^a   Mu, Bo Zhong ^a  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Bacillus subtilis; Carboxyl group; Hela cell; Structure; Surface activity; Surfactin

Indexed keywords

BACILLUS SUBTILIS; CARBOXYL GROUP; HELA CELL; STRUCTURE; SURFACE ACTIVITY; SURFACTIN;

ACIDS; AIR POLLUTION; BACTERIOLOGY; CELL CULTURE; CELL MEMBRANES; CRITICAL MICELLE CONCENTRATION; ESTERIFICATION; ESTERS; FATTY ACIDS; METHANOL; MICELLES; PRECIPITATION (METEOROLOGY);

SURFACE STRUCTURE;

BACILLUS SUBTILIS;

EID: 69249218967     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2009.06.014     Document Type: Article

References (50)

1. Peypoux F., Bonmatin J.M., and Wallach J. Recent trends in the biochemistry of surfactin. Appl Microbiol Biotechnol 51 (1999) 553-563
2. Liu X.Y., Yang S.Z., and Mu B.Z. Molecular structures of microbial lipopeptides. Biotechnol Bull (2005) 18-26
3. Grgurina I. Lipopeptide secondary metabolites from the phytopathogenic bacterium Pseudomonas syringae. In: Upadhyay R.K. (Ed). Advances in microbial toxin research and its biotechnological exploitation (2002), Kluwer Academic/Plenum Publishers, New York 105-140
4. Baltz R.H., Miao V., and Wrigley S.K. Natural products to drugs: daptomycin and related lipopeptide antibiotics. Nat Prod Rep 22 (2005) 717-741
5. Rosenberg E., and Ron E.Z. High- and low-molecular-mass microbial surfactants. Appl Microbiol Biotechnol 52 (1999) 154-162
6. Rodrigues L., Banat I.M., Teixeira J., and Oliveira R. Biosurfactants: potential applications in medicine. J Antimicrob Chemother 57 (2006) 609-618
7. Singh P., and Cameotra S.S. Potential applications of microbial surfactants in biomedical sciences. Trends Biotechnol 22 (2004) 142-146
8. Cameotra S.S., and Makkar R.S. Recent applications of biosurfactants as biological and immunological molecules. Curr Opin Microbiol 7 (2004) 262-266
9. Hosono K., and Suzuki H. Acylpeptides, the inhibitors of cyclic adenosine 3′, 5′-monophosphate phosphodiesterase. III. Inhibition of cyclic AMP phosphodiesterase. J Antibiot 36 (1983) 679-683
10. Bortolato M., Besson F., and Roux B. Inhibition of alkaline phosphatase by surfactin, a natural chelating lipopeptide from Bacillus subtilis. Biotechnol Lett 19 (1997) 433-435
11. Hwang Y.H., Park B.K., Lim J.H., Kim M.S., Park S.C., Hwang M.H., et al. Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock. Eur J Pharmacol 556 (2007) 166-171
12. Takahashi T., Ohno O., Ikeda Y., Sawa R., Homma Y., Igarashi M., et al. Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin. J Antibiot 59 (2006) 35-43
13. Bonmatin J.M., Laprevote O., and Peypoux F. Diversity among microbial cyclic lipopeptides: iturins and surfactins. Activity-structure relationships to design new bioactive agents. Comb Chem High Throughput Screen 6 (2003) 541-556
14. Chiocchini C., Linne U., and Stachelhaus T. In vivo biocombinatorial synthesis of lipopeptides by COM domain-mediated reprogramming of the surfactin biosynthetic complex. Chem Biol 13 (2006) 899-908
15. Symmank H., Franke P., Saenger W., and Bernhard F. Modification of biologically active peptides: production of a novel lipohexapeptide after engineering of Bacillus subtilis surfactin synthetase. Protein Eng 15 (2002) 913-921
16. Yakimov M.M., Fredrickson H.L., and Timmis K.N. Effect of heterogeneity of hydrophobic moieties on surface activity of lichenysin A, a lipopeptide biosurfactant from Bacillus licheniformis BAS50. Biotechnol Appl Biochem 23 (1996) 13-18
17. Thimon L., Peypoux F., Das B.C., Wallach J., and Michel G. Selective esterification of surfactin: preparation and properties of surfactin methyl esters. Biotechnol Appl Biochem 20 (1994) 415-423
18. 13C NMR spectral data of nine surfactin isomers. Magn Reson Chem 45 (2007) 792-796
19. Haddad N.I.A., Liu X.Y., Yang S.Z., and Mu B.Z. Surfactin isoforms from Bacillus subtilus HSO121: separation and characterization. Protein Pept Lett 15 (2008) 265-269
20. Liu X.Y., Namir I.A.H., Yang S.Z., and Mu B.Z. Structural characterization of eight cyclic lipopeptides produced by Bacillus subtilis HSO121. Protein Pept Lett 14 (2007) 766-773
21. Liu X.Y., Yang S.Z., and Mu BZ. Isolation and characterization of a C12-lipopeptide produced by Bacillus subtilis HSO121. J Pept Sci 14 (2008) 864-875
22. Lü Y.N., Yang S.Z., and Mu B.Z. Isolation and identification of a lipopeptide. Microbiology 32 (2005) 67-73
23. He F.Y., Zhang J.L., Li T.C., Dai H.J., and Hou D.Y. Fatty acid analysis of clam by GC/MS. Food Sci Biotechnol 31 (2006) 238-240
24. Yang S.Z., Wei D.Z., and Mu B.Z. Determination of the structure of the fatty acid chain in a cyclic lipopeptide using GC-MS. J Biochem Biophys Methods 70 (2006) 519-523
25. Yang S.Z., Wei D.Z., and Mu B.Z. Determination of the amino acid sequence in a cyclic lipopeptide using MS with DHT mechanism. J Biochem Biophys Methods 68 (2006) 69-74
26. Batrakov S.G., Rodionova T.A., Esipov S.E., Polyakov N.B., Sheichenko V.I., Shekhovtsova N.V., et al. A novel lipopeptide, an inhibitor of bacterial adhesion, from the thermophilic and halotolerant subsurface Bacillus licheniformis strain 603. Biochim Biophys Acta 1634 (2003) 107-115
27. Kowall M., Vater J., Kluge B., Stein T., Franke P., and Ziessow D. Separation and characterization of surfactin isoforms produced by Bacillus subtilis OKB 105. J Colloid Interf Sci 204 (1998) 1-8
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
29. Lü YN. Mutagenesis for biosurfactant-producing bacterium and the study of its metabolite. Master's Thesis. East China University of Science and Technology, China; 2004.
30. Yeh M.S., Wei Y.H., and Chang J.S. Bioreactor design for enhanced carrier-assisted surfactin production with Bacillus subtilis. Process Biochem 41 (2006) 1799-1805
31. Sen R., and Swaminathan T. Characterization of concentration and purification parameters and operating conditions for the small-scale recovery of surfactin. Process Biochem 40 (2005) 2953-2958
32. Wei Y.H., Lai C.C., and Chang J.S. Using Taguchi experimental design methods to optimize trace element composition for enhanced surfactin production by Bacillus subtilis ATCC 21332. Process Biochem 42 (2007) 40-45
33. Kim H.-S., Yoon B.-D., Lee C.-H., Suh H.-H., Oh H.-M., Katsuragi T., et al. Production and properties of a lipopeptide biosurfactant from Bacillus subtilis C9. J Ferment Bioeng 84 (1997) 41-46
34. Eliseev S.A., Shul'ga A.P., and Karpenko E.V. The characteristics of the biosynthesis of surface-active lipids by a Bacillus sp. culture. Mikrobiol Zh 52 (1990) 41-44 (in Russian)
35. Sheppard J.D., and Mulligan C.N. The production of surfactin by Bacillus subtilis grown on peat hydrolysate. Appl Microbiol Biotechnol 27 (1987) 110-116
36. Fonseca R.R., Silva A.J.R., De Franca F.P., Cardoso V.L., and Servulo E.F.C. Optimizing carbon/nitrogen ratio for biosurfactant production by a Bacillus subtilis strain. Appl Biochem Biotechnol 137 (2007) 471-486
37. Peypoux F., Bonmatin J.M., Labbe H., Das B.C., Ptak M., and Michel G. Isolation and characterization of a new variant of surfactin, the [Val7]surfactin. Eur J Biochem 202 (1991) 101-106
38. Nakayama S., Takahashi S., Hirai M., and Shoda M. Isolation of new variants of surfactin by a recombinant Bacillus subtilis. Appl Microbiol Biotechnol 48 (1991) 80-82
39. Milne C., Powell A., Jim J., AlNakeeb M., Smith C.P., and Micklefield J. Biosynthesis of the (2S, 3R)-3-methyl glutamate residue of nonribosomal lipopeptides. J Am Chem Soc 128 (2006) 11250-11259
40. Kiho T., Nakayama M., and Kogen H. Total synthesis and NMR conformational study of signal peptidase II inhibitors, globomycin and SF-1902 A(5). Tetrahedron 59 (2003) 1685-1697
41. Besson F., and Michel G. Isolation and characterization of news iturins: iturin D and iturin E. J Antibiot 40 (1987) 437-442
42. Fukuda D.S., Dubus R.H., Baker P.J., Berry D.M., and Mynderse J.S. A54145, a new lipopeptide antibiotic complex: isolation and characterization. J Antibiot 43 (1990) 594-600
43. 2+-induced changes of surfactin conformation: a FTIR and circular dichroism study. Biochem Biophys Res Commun 282 (2001) 361-367
44. Kracht M., Rokos H., Ozel M., Kowall M., Pauli G., and Vater J. Antiviral and hemolytic activities of surfactin isoforms and their methyl ester derivatives. J Antibiot (Tokyo) 52 (1999) 613-619
45. Kameda Y., Oira S., Matsui K., Kanatomo S., and Hase T. Antitumor activity of bacillus natto. V. Isolation and characterization of surfactin in the culture medium of Bacillus natto KMD 2311. Chem Pharm Bull (Tokyo) 22 (1974) 938-944
46. Wang C.L., Ng T.B., Yuan F., Liu Z.K., and Liu F. Induction of apoptosis in human leukemia K562 cells by cyclic lipopeptide from Bacillus subtilis natto T-2. Peptides 28 (2007) 1344-1350
47. Kim S.Y., Kim J.Y., Kim S.H., Bae H.J., Yi H., Yoon S.H., et al. Surfactin from Bacillus subtilis displays anti-proliferative effect via apoptosis induction, cell cycle arrest and survival signaling suppression. FEBS Lett 581 (2007) 865-871
48. Kikuchi T., and Hasumi K. Enhancement of plasminogen activation by surfactin C: augmentation of fibrinolysis in vitro and in vivo. Biochim Biophys Acta 1596 (2002) 234-245
49. Hasumi K., Takizawa K., Takahashi F., Park J.K., and Endo A. Inhibition of Acyl-CoA: cholesterol acyltransferase by isohalobacillin, a complex of novel cyclic acylpeptides produced by Bacillus sp. A1236. J Antibiot 48 (1995) 1419-1424
50. Kim K., Jung S.Y., Lee D.K., Jung J.K., Park J.K., Kim D.K., et al. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2. Biochem Pharmacol 55 (1998) 975-985